Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Accounts Payables (2016 - 2025)

Skinvisible (SKVI) has disclosed Accounts Payables for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 45.95% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 45.95% year-over-year, with the annual reading at $1.3 million for FY2025, 45.95% up from the prior year.
  • Accounts Payables hit $1.3 million in Q4 2025 for Skinvisible, up from $1.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.3 million in Q4 2025 to a low of $126057.0 in Q1 2023.
  • Historically, Accounts Payables has averaged $853376.1 across 5 years, with a median of $972449.0 in 2021.
  • Biggest five-year swings in Accounts Payables: soared 10167.88% in 2021 and later crashed 86.66% in 2023.
  • Year by year, Accounts Payables stood at $1.0 million in 2021, then rose by 15.61% to $1.2 million in 2022, then crashed by 63.5% to $438668.0 in 2023, then surged by 95.82% to $858993.0 in 2024, then skyrocketed by 45.95% to $1.3 million in 2025.
  • Business Quant data shows Accounts Payables for SKVI at $1.3 million in Q4 2025, $1.2 million in Q3 2025, and $1.1 million in Q2 2025.